EVGN
Evogene Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.50
−0.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 9.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -2.40x
- Price / sales
- 6.03x
- Price / cash flow
- -0.68x
Enterprise value
- Enterprise value
- $9.7M
- EV / sales
- 7.42x
- EV / EBITDA
- -0.77x
- EV / EBIT
- -0.72x
- Market cap
- $7.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026